15
Parasite - an organism that lives in or on another organism (the host) and benefits by deriving nutrients at host's expense Impact on humanity Phylogenetic tree of life Antiparasitic drugs; malaria and the forgotten ones Baran group meeting October 4 th , 2014 Kevin M. Oberg I m p a c t o n h u m a n i t y Neglected Tropical Diseases (NTDs) affect more than 1 billion people. 11/18 NTDs are parasites. Impact hardest on poor, developing countries. decreased health decreased health economic drag lack of money for treatment Neglected Parasitic Infections in USA Chagas disease - 300,000 infected Neurocysticercosis (tapeworm) - 1,000 yearly hospitalizations Toxocariasis - 14% population exposure Global society (shipping and Toxocariasis 14% population exposure 70 people blinded yearly Toxoplasmosis - 60 million infected Trichomoniasis - 3.7 million infected Global society (shipping and traveling), immunosuppresion, still endemic Transmission - direct, fecal-oral, vector, predator-prey Giardia Malaria prokaryote eukaryote haploid (1 copy of chromosomes) = point mutation means immediate phenotype expression diploid (2 copies of chromosomes) = point mutation could be recessive or dominant cyst trophozoites zygotes ookinetes oocysts sporozoites schinzonts merozoites mosquito liver blood human vs. animal resevoir - resistance in humans directly transmitted and possibility of eradication inate defenses gene amplification - more targets for drug and organism survival enhanced gene mutation - drug target changes and resistance emerges www.cdc.gov www.who.int zygotes gametocytes Challenges in combating inf ectious parasitic disease *parasites range from simple eukaryotes that posses bateria cellular mechanisms to multicelled "higher" organisms that share many of the same gene mutation drug target changes and resistance emerges - drug transport machinery changes - drug efflux increases many drugs were emperically discovered and most of the mechanisms of action remain unknown so resistance pathways are also not understood M o l e c u l a r B i o l o g y o f P a r a s i t i c P r o t o z o a , Oxford University Press, 1996. cellular processes as hosts *parasite have evolved to evade host immune system and even evidence of cooevolution (sickel cell) *fast generation times, organism ploidy, reservoir, vectors developing resistance, natural resistance mechanisms, ability to transfer resistance *lack of funding as most heavily affected regions tend to poorer

Baran group meeting Antiparasitic drugs; malaria and the ... · Parasite- an organism that lives in or on another organism (the host) and benefits by deriving nutrients at host's

  • Upload
    others

  • View
    11

  • Download
    0

Embed Size (px)

Citation preview

Parasite - an organism that lives in or on another organism (the host) andbenefits by deriving nutrients at host's expense

Impact on humanity

Phylogenetic tree of life

Antiparasitic drugs; malaria and the forgotten onesBaran group meetingOctober 4th, 2014 Kevin M. Oberg

Impact on humanityNeglected Tropical Diseases(NTDs) affect more than 1 billionpeople. 11/18 NTDs are parasites.Impact hardest on poor, developingcountries.

decreased healthdecreased health

economic draglack of moneyfor treatment

Neglected Parasitic Infections in USAChagas disease - 300,000 infectedNeurocysticercosis (tapeworm) - 1,000

yearly hospitalizationsToxocariasis - 14% population exposureGlobal society (shipping and Toxocariasis 14% population exposure

70 people blinded yearlyToxoplasmosis - 60 million infectedTrichomoniasis - 3.7 million infected

Global society (shipping andtraveling), immunosuppresion,still endemic

Transmission - direct, fecal-oral, vector, predator-preyGiardia Malaria

prokaryote eukaryote

haploid (1 copy of chromosomes) = point mutation means immediatephenotype expressiondiploid (2 copies of chromosomes) = point mutation could be recessive ordominant

cyst

trophozoites

zygotes

ookinetes

oocystssporozoites schinzonts

merozoitesmosquito

liver

blood

human vs. animal resevoir - resistance in humans directly transmitted andpossibility of eradication

inate defensesgene amplification - more targets for drug and organism survival enhancedgene mutation - drug target changes and resistance emerges

www.cdc.govwww.who.int

zygotes

gametocytes

Challenges in combating infectious parasitic disease*parasites range from simple eukaryotes that posses bateria cellularmechanisms to multicelled "higher" organisms that share many of the same

gene mutation drug target changes and resistance emerges- drug transport machinery changes- drug efflux increases

many drugs were emperically discovered and most of the mechanisms ofaction remain unknown so resistance pathways are also not understood

Molecular Biology of Parasitic Protozoa, Oxford University Press, 1996.

cellular processes as hosts*parasite have evolved to evade host immune system and even evidence ofcooevolution (sickel cell)*fast generation times, organism ploidy, reservoir, vectors developingresistance, natural resistance mechanisms, ability to transfer resistance*lack of funding as most heavily affected regions tend to poorer

Kevin M. ObergBaran group meetingOctober 4th, 2014 Antiparasitic drugs; malaria and the forgotten ones

Kevin M. ObergBaran group meetingOctober 4th, 2014 Antiparasitic drugs; malaria and the forgotten ones

Kevin M. ObergBaran group meetingOctober 4th, 2014 Antiparasitic drugs; malaria and the forgotten onesJacobsen (Harvard): 2004

OMe 1. Et2AlCl, thioanisole2

OMeOTBS

1. H2, Ni2. LDA, H2O

J A Ch S 2004 126 706cat asymm

NH

O

CO2MeTBSO

CO2Me

N

N

CBzO

2.N

OHN

OTBS

HN

O

Cbz CN

CrCl2,O

BO

Cl Cl

MeMeMe

Me

J. Am. Chem. Soc. 2004, 126, 706.

Kobayashi (Tokyo Institute of Technology): 2004

HO OAR 1. O3, NaBH4

2. I2, PPh3, im

cat. asymm.conj. add.

O

R

Bpin

Pd(OAc)2, SphosK3PO4,

MeOBr

N

OMe

HO OAc 2, 3,3. BnNH2

TBDPSOOPiv O

OMe

PO

OEtOEt

NCBz

R

asymmetricepoxidationfailed so...

NCBz

N

N

N

CBz AD-mix-

OMe

NBn

TBDPSO

NBz

O

N

P OEt

N

N

CBzHO

OHNBz

OMe

i. MeC(OMe)3

O

O

R

R

MeOMe ii. AcBr

iii K COOMe

N

OMe1. AD-mix-2. MeC(OMe)3,

TMSCl, K2CO33. DIBAL4

Tetrahedron Lett. 2004, 45, 3783.

N

Tetrahedron 1992, 48, 10515.

O

O

R

RMe+

OAc

R

R

Br

iii. K2CO3,MeOH N

N

CBzOOH

N

4.

use of AD-mix- allows for quinidine access

Chloroquine (Resochin)Andersag (Bayer): 1934

Drugs brought to you by war time effortsCl

Kevin M. ObergBaran group meetingOctober 4th, 2014 Antiparasitic drugs; malaria and the forgotten ones

N

S+ NMe2Me2N

NCl

HN

Me

NEt2

Methylene blueN

HONH

CF3

Cl- Cl

Bu N

ClCl

CF3

OH

Benflumetol (lumefantrine):synthesized by Acadamy ofMilitary Medical Sciences,Beijing

NCl

inhibits hemozoin formation: Biochimica et Biophysica Acta 2014, 1840, 2032. Mefloquine: Rush-Presbyterian-St.Luke's Army MalariaResearch Projectwith Walter Reed

CF3

C 3OH

Bu2N

EtO2C

Cl

NBu2

Halofantrine: SRIInternational contract forWalter Reed Army

Me

with Walter ReedArmy Institute ofResearch

Qinghaosu (Artemisinin)Cl NH2

CO2EtO

EtO2C

Cl N CO2Et

CO2Et

Walter Reed ArmyInstitute of Research

青蒿素

OO

OO

Me

HMe

HMe

O

Cl N CO2Et

OH

Cl N

OH

O

Project 523lead investigator: Youyou Tu

China Academy of Chinese Medical Sciences

POCl3

Cl N

Cl

NCl

HN

Me

NEt2RNH2

Parasitol Res. 2012, 111, 1.

WHO technical report ser ies 1990, 805Gutekunst GM Molecules of Traditional Chinese medicine 2009Cell 2011, 146, 855.

mechanism of action still not completely understoodfast acting: normally paired with benflumetol (slower acting)

NCl

5 step racemic synthesis = millions of saved lives

Kevin M. ObergBaran group meetingOctober 4th, 2014 Antiparasitic drugs; malaria and the forgotten ones

Wei-Shan (Shanghai Institute of Organic Chemistry): 1983

Me MeO

Hofheinz (Hoffmann-La Roche): 1983

Me Me 1 HCl MeOHMe

O

MeMe

1. ZrBr22. BH33. BnCl4. CrO3

Me

O

MeOB

HLDA,

TMSO

MeMe

O

Me

H

Me

JACS 1973, 95, 6152.GM Burns: Stork

8

Me

HO

1. MOMCl2. BH33. BnBr

Me

MOMO

Me

H

OBn

1. HCl, MeOH2. PCC3. LDA, I TMS

Me

JACS 1974, 96, 3682.GM Burns: StorkBnO (-)-isopulegol

OBn MeGM Burns: Stork

1. Ba(OH)22. (CO2H)2

Me

HO

1. MeMgI2. TsOH3. Na, NH34. CrO35 CH2N2

Me

HMeH

OBn

O

Me MeMe

LiCH(OMe)TMS HOMeO

Me

TMS TMS

1. Li, NH32. PCC

(-)-citronellal

MeOBn

H 5. CH2N2MeO2C Me

also synthesized f romarteannuinic acid

1. O32. (HSCH2)2

+

Me

M

O MeMe

Me

O H

OBnMeBnO

HTMS

TMS MeMe

OO

1O 78 °C3. HC(OMe)3, H+

4. HgCl2, CaCO3

MeO2C Me

HMeO

Me

MeO2C Me

H(MeO)2HCO

O

MeMeO

Huaxue Xuebao 1983, 41, 574.T t h d 1986 42 819

Me

H

Me

OTMS

MeO1. mCPBA2. TBAF H

MeOMeHO2C

1O2, -78 °CMeOH

Me

H

Me

MeOMeHO2C

MeOHOO

1O2, -78 °CMeOH

HClOTetrahedron 1986, 42, 819. O assumed

HCOOH

OO

OO

Me

Me

HMe

Qinghaosu

OMeH

R"warm" non-polar solvent

polar solvent"cool" (-78 °C)OMeR OO

HClO4

MeR

HOO

1O2, 23 °CDCM

O

J. Am. Chem. Soc. 1983, 105, 625.GM Maimone 2005 Classic Terpene

Qinghaosu

OMeR

J. Am. Chem. Soc. 1980, 102, 3644.GM McKerrall 2011, singlet O2

p cool ( 78 C)

OOH ene [2+2]OO

OMeR

MeHO2CMeO

Kevin M. ObergBaran group meetingOctober 4th, 2014 Antiparasitic drugs; malaria and the forgotten onesAvery (SRI International): 1987, 1992

MeMe

MeMeRoth (George Mason University) and Acton (Walter Reed Army Insititute ofResearch): 1989

Me

Me Me

O1. HOO-

2. NaSPh3. mCPBA

SO

Me

PhO

1. LDA,2. Al-Hg

MeOO

Br

Me

HO2C Me

HMeH

O2, methylene blue

OO

OO

Me

Me

HMe

O(+)-pulegone

O

Me

MeOO

MeMe

1. TsNHNH22. nBuLi, DMF

Me

MeOO

MeMe

O

i. TMS3Alii. Ac2O

2

dihydroartemisinic acidOArtemisinin

J. Nat. Prod. 1989, 52, 1183.

MeHock cleavage

Me

M

O

O

Me

MeOO

MeMe

i. LDEAii LDA M I

Me

MeOO

MeMe

O

HO2C Me

HHOO

Me

g3O2

HO2C Me

H

for mechanism: Org. Process Res. Dev. 2014, 18, 417.GM Yuan Peroxide Chemistry (2014)

HOOMe

O

MeTMS

O

O

Me

ii. LDA, MeI Me

H

HO2C Me

TMSO3

MeMe

Me

Ravindranathan (National Chemical Lab): 1990

H

Me

Me H

Me

H

1.2. mCPBA3. LiAlH4 HO

Me

GM Yuan Peroxide Chemistry (2014)

J. Am. Chem. Soc.1978, 100, 294.

Me

TMSOH2SO4,SiO2

MeOO

MeMe

O

OHO

OO

OO

Me

Me

HMe

MeMe

H

MeO

H

MeO

HMe

1. RuCl3, NaIO42. NaOMe, MeOH

Me

HO

1. NaOMe2. NaIO43. CH2N2

Me

Me

O

O

(+)-3-carene

H

HO2C Me

O O H

HO2C Me

OO

MeO

Tetrahedron Lett. 1987, 28, 4629.J. Am. Chem. Soc. 1992, 114, 974.

"This work was funded by the U.S. ArmyContract number DAMD-17-85-C-5011."

H

MeO

HHO

Me

O Wei-Shan int.

Artemisinin

3. CH2N2

Syn. Commun. 1980, 10, 205.

Me

H

MeO2C

Tetrahedron Lett. 1990, 31, 755.

Kevin M. ObergBaran group meetingOctober 4th, 2014 Antiparasitic drugs; malaria and the forgotten onesLiu (University of Alberta): 1993

1. O3O O

M O C

Constantino (Universidade de Sao Paulo): 1996

Me MeTMS

O

Me

MeMe

2. NaH,3. PhSeCl, py

MeO OMe

Tetrahedron Lett. 1991, 32, 2005.

MeMe

MeO2C

(-)- -pinene

ZnCl2, isopreneMe

HO H

Me( ) i l l

1. BH32. BnCl3. PDC

Me

O H

MeOB

1. LDA,2. Ba(OH)23. (CO2H)2

Me

O

MeMe

Me

MeO2C

H

O2, TPP, hvAc2O, py, DMAP

O

MeMe

Me

MeO2C

H

O1. (HSCH2)22. LiI, collidine

(-)-isopulegol OBnMe

HO

1. H2, Pd/C2. PDC

Me

HOH

1. MeLi2. TsOH

JOC 1983 48 4135 H

O

MeMe

MeH

S

S

1. TsOH, (HOCH2)22. TsOH, acetone3. NaOH, MeOH

O

MeH

S

S

H

MeOBn

HO2C Me

Me

M

1. 1O22. TFA, O2

ArtemisininWei-ShanRoth/Acton

JOC 1983, 48, 4135

Me1.2. TsOH, acetone3. NaOH, MeOH4. LiAlH45. MsCl, NEt36. LiAlH4

Ph3P OMeMe

MeH

S

S

H

1. HgCl22. NaBH4, CeCl33. BzOH, PPh3, DEAD

HO2C Me

HMeH

Keasling (Berkeley): 2004

engineered

Me

Me

HMeH

Me

Me

MeH H

BzO1. 9-BBN2. H2CrO43. K2CO3, MeI4. NaBH4, NiCl2

1. 1O22. TFA, O2

sugar S. cerevisiae

HO2C

HMeH

Nature 2006, 440, 940.

Artemisinin

Institute OneWorld HealthGates Fnd.Akibene Fnd

artemisinic acid

Tetrahedron Lett. 1993, 34, 4435.

HO2C Me

HHH H

MeQinghaosu

works on trans acid

Improvements; Nature 2013, 496, 528.

Seeberger (Max-Planck Institute): 2012

Angew. Chem. Int. Ed. 2012, 51, 1706.

Akibene Fnd.

Roth/Acton process done in flow

Kevin M. ObergBaran group meetingOctober 4th, 2014 Antiparasitic drugs; malaria and the forgotten ones

Kevin M. ObergBaran group meetingOctober 4th, 2014 Antiparasitic drugs; malaria and the forgotten onesAfrican trypanosomiasis (sleeping sickness) - caused by Trypanosoma brucie 2nd stage - central nervous system has been invaded

NH2 S OH

tsetse fly humans

Sanofi Aventis and Bayer produce and donate all anti HAT drugs to the WHO

N

N

N

NH

H2N

NH2As S

S OH

melarsoprol

East African species - death w/in couple monthsWest African species - death w/in couple years

Toxic: 2.5-5% mortality

inhibits glycolysis? binds trypanothione?mechanism unknown...

Sanofi-Aventis and Bayer produce and donate all anti-HAT drugs to the WHO

1st stageO O

HN NH2

pentamidine

H2NCO2H

CHF2H2N

eflornithine

treatment for hirsutism (rapidly dividing cells)kills trypanosoma (ornithine decarboxylaseneeded)

NH2 NHpentamidine

binds ubiquitin and/or DNA? mechanism unknown...Chem. Biodivers. 2005, 2, 1387.

O HNO

OSO3H

irreversible inhibitor for ornithine decarboxylase (makes polyamines andneeded for cell division)J. Biological Chem. 1992, 267, 150.

H NH2arginaseNH2

suramin coloroless

inhibits glycolysis? mechanism unknown...

NH

NH

N

O

O

NH

NHO

Me

SO3H

NH

Me HO3S SO3H

NCO2H

H2N

NHarginine

arginaseH2NCO2H

ornithine

also nifurtimox - see Chagas diseaseinhibits glycolysis? mechanism unknown...

NN

MeMe

NHOH2N

N OHNH2

NHO SO3H

SO3HSO3H O

NH

NHHN

NHMeO MeO

pafuramidineSO3H

2

HO3S

2HO3S

SO3Htrypan blue

Ehrlich had demonstrated polynaphthalene dyes to have trypanocidal activity

pafuramidinekilled in phase III due to kidney toxicity

Toxicol. Sci. 2012, 130, 416.

Kevin M. ObergBaran group meetingOctober 4th, 2014 Antiparasitic drugs; malaria and the forgotten onesAmerican trypanosomiasis (Chagas disease) - caused by Trypanosoma cruzi Giardiasis (beaver fever) - caused by Giardia lamblia

most common parasitic infection worldwide

kissing bug humans

-1st stage, mild symptoms-2nd stage, chronic - 10-30 years 1/3 get heart failure, enlargedesophagus/colon

most common parasitic infection worldwide

cysts humans3-7% in the USsome developing countries, up to 30%

N

NMe

NH

O

N NO2

p g /Lancet 2010, 375, 1388.

NHO

R

NH2O

NH

NH2

NHR4 e-

Ph

usually mild symptoms NO2N OH

metronidazoletreatment with nitroimidazoles

www.cdc.gov

N

NO2

benznidazole

NHO

Antimicrob. Agents Chemother. 2012, 56, 115.

OO

nitroreductase Cryptosporidiosis - caused by Cryptosporidium

cysts humans

treatment primarily supportive

SN

NMe

O

ONO2

nitroreductase ON

not oxidative stresses H2N

NH2O

O

O

H2NHO

HO

OH

OHOHONH2OH

OAc O

NH

N

SNO2

O nifurtimox

these drugs cure up to 80% of acute phase patientsJ. Biol. Chem. 2011, 286, 13088.Biochemical Pharmacology 2010, 79, 1736.

R OHO

2

OHH2NO

paromycintypically used as a antibiotic

nitazoxanide

OHO

cure rate drops to 5-20% for chronic patientsO

Cl atovaquone(ubiquinone analogue)

www.cdc.gov

Kevin M. ObergBaran group meetingOctober 4th, 2014 Antiparasitic drugs; malaria and the forgotten ones

Toxoplasmosis (cat poop parasite) - caused by Toxoplasma gondii

b t 10 80% i f ti i diff t i

Leishmaniasis - caused by Leishmania

feline rodents/livestock

humans

between 10-80% infection in different regions

acute: influenza-like, immunocompromizationcan lead to encephalitis or eye damagelatent: cysts in nervous and muscle tissuecutaneous: skin lesions

sandflies humans

Pentavalent Sb introduced in the 1940's+ OH

cutaneous (common) - open sore on skinvisceral - internal organs (usually spleen, liver,bone)

congenital toxoplasmosis - infection of the fetus from an infected mother(worst case: miscarriage, birth defects, vision impariment)

NOMe

O

O

O

O

OH

OH

HOHN

Me

HNMe

OH

HO

HO

Sb

+

O SbOO

ONa

O

SbOO

OH

O

NaO2C

HO

OHCO2Na

OHHON

EtCl

NOMe

OMeNH2H2N

trimethoprim

SOO ON

Me paropmycin pentamidine neomycin sitamaquine (chloroquine derivative)

meglumine antimonate

structure elucidation: Antimicrobial Agents and Chemotherapy 1998, 42,1076. J. Inorg. Biochem. 2008, 102, 656.

NaO2C OH

sodium stibogluconate

SOO N

N NH2H2N

pyrimethamine

H2N

SNH

sulfamethoxazole

inhibit folate synthesisgiven with folinic acid for patient

paropmycin, pentamidine, neomycin, sitamaquine (chloroquine derivative)

O

HOMe

Me

O OH OH

OH

OH OH O

OHOH

CO2H

H2N

SNH

N

sulfadiazine

O

SMe

HOHO

OHHN O

Me

ClMe

Me

O

CO2H

O Me

OHNH

HOamphotericin Bactually an antifungal agentbinds ergosterol in cell membrane leading to pores

N

N N

NO

H2N

NH

NH

O

CO2H

HO2C OH

NMe

nPr

clindamycinantibiotic for cyst killing

www.cdc.orgAntibiotics: Actions, Origins, Resistance. 2003, ASM Press, Washington, D.C.

NH2binds ergosterol in cell membrane leading to poresless of this sterol in mammalian, but still toxicfor syntheses, see; Classics in Total Synthesis INicolaou: J. Am. Chem. Soc. 1987, 109, 2821.

NH

NH

H2N HO2C

Folic acid

Kevin M. ObergBaran group meetingOctober 4th, 2014 Antiparasitic drugs; malaria and the forgotten ones

Amoebiasis - caused by Entamoeba histolyticaHO NF

N

Nfluconazole and other triazoles

b t ti

OO INMe Cl

NF

N

NN

inhibits 14 -demethylase(mamalian enzyme is less sensitive)

cyst humanscan be asymptopticsymptoms develop over weeks - diarrheacan move from intestines to systemic and causesome real problems

OP

ONMe3

miltefosine NOH

I

diiodohydroxyquinoline

O

O

O

N

OCl

diloxanide furoate

Me

OH

HR O

Olysophosphatidylcholines

Akt inhibitor

antileishmaniasm activity overlooked due to potential anticancer propertiesoral bioavailability, but long treatment times coupled with possibleteratogenicity may hinder global useJ. Antimicrob. Chemother. 2012, 67, 2576.

lots of antibiotics as well

Amoebic keratitis - caused by Acanthamoeba

usually affects contact users

Trichomoniasis (STD) - caused by Trichomonas vaginalis

170 million worldwide

Chem. Rev. A.S.A.P. dx.doi.org/10.1021/cr4000552x

HN

HN

HN

NH

NH

ClNH NH

NH NH

NH

Cl

chlorhexidine

females males (inapperant infections in women up to 50%and higher in men)

N

N

O NMe

OHonly approved drug in US Primary amoebic meningoencephalitits - caused by Naegleria fowler i

Journal of Medical Microbiology 2008, 57, 1399.

Clin. Microbiol. Rev. 2004, 17, 783.

O2N OH

metronidazole

resistant strains have been detected... Primary amoebic meningoencephalitits - caused by Naegleria fowler i

free-living human nervous system "brain-eating amoeba"95% fatality rate

treatment with amphotericin, miconazole, miltefosine, the kitchen sink

Kevin M. ObergBaran group meetingOctober 4th, 2014 Antiparasitic drugs; malaria and the forgotten onesHelminths (worms) - platyhelminths (flatworms), acanthocephalins (thorny-headed worms), nematodes (roundworms)

Onchocerciasis (river blindness or Robles disease) - caused by Onchocercavolvulus

eggs/larva humansvia poor hygenineor vectors

Drugs act in two ways: killing or stunning

black fly humans

MeO Avermectins

HN

OOMe

O

MeNN NEt2

O

OO

MeMeO

Me

OMeO

OMe

OMeHO

MeO

OH

Avermectins

killers:

NNH

mebendazole

inhibits microtubule synthesis

MeN

diethylcarbamazinearachidonic acid metabolism inhibitor

MeO

Me/EtO

MeO

HO

GM Z f 2004 S th i f I id l

total syntheses of avetmicins, see;Hanessian: Pure & Appl. Chem. 1987, 59, 299.Danishefky: J. Am. Chem. Soc. 1989, 111, 2967.White: J. Am. Chem. Soc. 1995, 117, 1908.Ley: J Chem Soc Perkin 1991 667

NH

OCl

Cl

NO2

O

OH/OMeMeGM Zografos 2004 Synthesis of Imidazoles Ley: J. Chem. Soc. Perkin.1991, 667.

stunners:

in vivo screening: "by no means serendipitous;those who were seeking found what they sought."

OHCl

niclosamide (tapeworms)oxidative phospholytion decouplerNature 1969, 221, 1016.

MeNS

N

O

Cy

O

praziquantel

thousands of microbialfermentation products

Nematospiroides dubiusinfected mice

isolation of avermectinsfrom Kitasato Institute (OS-3153) - Streptomycesavermitilis "capable ofseparating from worms"

N

NS

pyrantel pamoatedepolarizing neuromuscalar blocking reagent

p qmembrane disruption and paralysis

ACS Symposium Series, 255, 5. doi: 10.1021/bk-1984-0255.ch001Int. J. Pharm. Pharm. Sci. 2011, 3, 17.

Kevin M. ObergBaran group meetingOctober 4th, 2014 Antiparasitic drugs; malaria and the forgotten ones

Streptomycesavermitilis fermentation avermectin H2, (PPh3)3RhCl

MeMeOMeO

OMe

OMeHO

MeO

OO

O

MeO

Me/EtO

Me

HOivermectininteracts with ligand gated

B1aB1b

OHMeO

channels causing paralysis

donations by Merck to WHO for erradication

MeN

Me Me

O NO

NMeMe

OO

Me

OEmodepsidecauses paralysis throughexcessive neurotransmitter release

O

ONMe

Me

MeO

MeO

OMeN

OO O

NMe

Me

Me

NO

Solid phase synthesis; see, Eur J Org Chem 2012, 1546.

Me

Me

Int. J. Animicro. Agents 2003, 22, 318.